Ensign Peak Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$137K	Hold	14,400	–	–	﹤0.01%	1483
2025 Q4	$112K	Sell	14,400 -32,400	-69%	-$234K	﹤0.01%	1544
2025 Q3	$355K	Sell	46,800 -41,600	-47%	-$346K	﹤0.01%	1527
2025 Q2	$792K	Hold	88,400	–	–	﹤0.01%	1383
2025 Q1	$663K	Hold	88,400	–	–	﹤0.01%	1456
2024 Q4	$665K	Hold	88,400	–	–	﹤0.01%	1518
2024 Q3	$672K	Hold	88,400	–	–	﹤0.01%	1521
2024 Q2	$546K	Hold	88,400	–	–	﹤0.01%	1581
2024 Q1	$449K	Sell	88,400 -4,460	-5%	-$25.1K	﹤0.01%	1646
2023 Q4	$556K	Hold	92,860	–	–	﹤0.01%	1638
2023 Q3	$657K	Hold	92,860	–	–	﹤0.01%	1479
2023 Q2	$654K	Hold	92,860	–	–	﹤0.01%	1535
2023 Q1	$774K	Buy	92,860 +11,300	+14%	+$109K	﹤0.01%	1441
2022 Q4	$936K	Buy	81,560 +28,200	+53%	+$352K	﹤0.01%	1216
2022 Q3	$672K	Buy	53,360 +1,530	+3%	+$19.7K	﹤0.01%	1302
2022 Q2	$548K	Hold	51,830	–	–	﹤0.01%	1425
2022 Q1	$843K	Hold	51,830	–	–	﹤0.01%	1300
2021 Q4	$718K	Buy	+51,830	New	+$686K	﹤0.01%	1450